Titre (en)
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « Titre (en) » - entrée « efficacy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
effects < efficacy < efficiencies  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000101 (2013) Stewart A. Factor [États-Unis] ; Kenneth Wolski [États-Unis] ; Daniel M. Togasaki [États-Unis] ; Susan Huyck [États-Unis] ; Marc Cantillon [États-Unis] ; T. W. Ho [États-Unis] ; Robert A. Hauser [États-Unis] ; Emmanuelle Pourcher [Canada]Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
000124 (2013) B. T. Van Poorten [Canada] ; S. P. Cox [Canada] ; A. B. Cooper [Canada]Efficacy of harvest and minimum size limit regulations for controlling short‐term harvest in recreational fisheries
000125 (2013) K. A. Papp [Canada] ; R. G. Langley [Canada] ; B. Sigurgeirsson [Islande] ; M. Abe [Japon] ; D. R. Baker [États-Unis] ; P. Konno [Estonie] ; S. Haemmerle [Suisse] ; H. J. Thurston [Suisse] ; C. Papavassilis [Suisse] ; H. B. Richards [Suisse]Efficacy and safety of secukinumab in the treatment of moderate‐to‐severe plaque psoriasis: a randomized, double‐blind, placebo‐controlled phase II dose‐ranging study
000162 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
000220 (2012) Anwen M. Harries [Canada] ; Shannon Major [Canada] ; Mandeep Sandhu [Canada] ; Christopher R. Honey [Canada]Rechargeable Internal Neural Stimulators—Is There a Problem with Efficacy?
000B96 (2006) Joy Noel-Weiss [Canada] ; Vicki Bassett [Canada] ; Betty Cragg [Canada]Developing a Prenatal Breastfeeding Workshop to Support Maternal Breastfeeding Self‐Efficacy
000C88 (2005) Jean-Claude Tardif [Canada] ; Ian Ford [Royaume-Uni] ; Michal Tendera [Pologne] ; Martial G. Bourassa [Canada] ; Kim Fox [Royaume-Uni]Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
001099 (2001) Andrew D. Krahn [Canada] ; George J. Klein [Canada] ; Raymond Yee [Canada]A Randomized, Double‐Blind, Placebo‐Controlled Evaluation of the Efficacy and Safety of Intravenously Administered Dofetilide in Patients with Wolff‐Parkinson‐White Syndrome
001223 (2000) Marie-Josée Bourque [Canada] ; Louis-Eric Trudeau [Canada]GDNF enhances the synaptic efficacy of dopaminergic neurons in culture
001246 (2000) Lionel H. Opie [Allemagne] ; Salim Yusuf [Allemagne] ; Wolfgang Kübler [Allemagne, Afrique du Sud]Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies
001550 (1998) Paul E. Nolan Jr. [États-Unis] ; Jean Nappi [États-Unis] ; P. Timothy Pollak [Canada]Clinical Efficacy of Amiodarone
001972 (1995) Kathy Steece-Collier [États-Unis] ; David M. Yurek [États-Unis] ; Timothy J. Collier [États-Unis] ; Fred S. Junn [Canada] ; John R. Sladek Jr. [États-Unis]The detrimental effect of levodopa on behavioral efficacy of fetal dopamine neuron grafts in rats is reversible following prolonged withdrawal of chronic dosing
001B93 (1994) Felicia H. Figa [Canada] ; Robert M. Gow [Canada] ; Robert M. Hamilton [Canada] ; Robert M. Freedom [Canada]Clinical efficacy and safety of intravenous amiodarone in infants and children
001D97 (1992) James W. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
001F80 (1991) Marion Tipple [Canada] ; George Sandor [Canada]Efficacy and Safety of Oral Sotalol in Early Infancy
002316 (1987) Mohammad Shenasa [Canada] ; Martin Fromer [Canada] ; Gerard Faugere [Canada] ; Reginald Nadeau [Canada] ; Robert A. Leblanc [Canada] ; Chantal Lambert [Canada] ; Mohammad Ali Sadr-Ameli [Canada]Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
002379 (1987) Denis Roy [Canada] ; Martine Montigny [Canada] ; George J. Klein [Canada] ; Arjun D. Sharma [Canada] ; Dennis Cassidy [Canada]Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "efficacy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "efficacy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    efficacy
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022